Quanying Zhang

2PUBLICATIONS
2CO-AUTHORS
PharmacogenomicsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 14, 2026
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral TYK2 Inhibitor D-2570 in Healthy Subjects: A First-in-Human Phase I Study.

Meng Wang, Quanying Zhang, Zhe Shi

|Nov 10, 2020
A Phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX02 to reference CN- and EU-sourced trastuzumab in healthy subjects.

X Zhu, Y Ding, Y Yu

Pageof 1

Frequent Collaborators

1 joint publications

Meng Wang

1 joint publications

Jie Pan